High Prevalence of Epiphora to Aid in Growth of Nasal Lacrimal Stent Market

Nasal Lacrimal Stent Market

 Nasal lacrimal stent is used in the treatment of trauma, infection, malignancy, thermal injury, chemotherapy, radiation, and iatrogenic causes. Increasing cases of trauma are expected to aid in growth of the nasal lacrimal stent market. According to January 2018 factsheet of the World Health Organization, 20–30% of older people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head trauma, in the U.S. Increasing geriatric population is also expected to aid in growth of the market. According to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050.

In the nasal lacrimal stent market, nasal lacrimal stents are typically classified into bicanalicular stents and monocanalicular stents. Bicanalicular stents can be further divided into Crawford stent, Ritleng Stent, Pigtail/Donut stent, and Kaneka Lacriflow stent and monocanalicular stents can be further divided into Monoka Stent and Jones Tube.

Nasal lacrimal stents can be used in the treatment of epiphora, an overflow of tears onto the face, other than caused by normal crying. The prevalence of postoperative epiphora was 3.6% and it persisted for a mean of 32.7 days, as per the study ‘Prevalence of nasolacrimal canal obstruction and epiphora following maxillary orthognathic surgery’ published in 2018. Thus, high prevalence of epiphora is expected to aid in growth of the nasal lacrimal stent market.

High prevalence of canalicular obstruction is also expected to aid in growth of the nasal lacrimal stent market. Nasal lacrimal stents also play a major role in the management of idiopathic distal canalicular obstructions. Congenital nasolacrimal duct obstruction is a common condition causing excessive tearing or mucoid discharge from the eyes, due to blockage of the nasolacrimal duct system. The frequency of canalicular obstruction has been reported to be between 16 and 25% in patients presenting with obstructive epiphora.

Placement of nasolacrimal stents can result in some complications, which is expected to limit growth of the nasal lacrimal stent market. The complications include, prolapse of the stent, damage to the puncta, granuloma formation, trauma to the canalicular system with creation of a false passage, and infection of the nasolacrimal drainage system. Moreover, the success rate of the nasolacrimal stent decreases as follow-up lengthens, which also limits their adoption.

In-depth Report on Nasal Lacrimal Stent Market by Coherent Market Insights:

https://www.coherentmarketinsights.com/ongoing-insight/nasal-lacrimal-stent-market-3183

Comments

Popular posts from this blog

Growing The Production And Sales Of Racing Cars And High-Performance Vehicles To Boost The Automotive Roller Tappets Market

Dextrin Is A Food Product That Has Properties Identical To Both Glucose And Maltodextrin

Oligonucleotide Synthesis Market Is Witnessing Robust Growth With Agilent Technologies Announcing To Invest Us$ 150 Million To Double Its Production Capacity For Oligonucleotides In Colorado, U.S.